(Q36938442)

17 August 2017

Double blind study of intrathecal beta-interferon in multiple sclerosis: clinical and laboratory results (English)

1 reference

17 August 2017

0 references

Milanese C

1

1 reference

17 August 2017

Salmaggi A

2

1 reference

17 August 2017

La Mantia L

3

1 reference

17 August 2017

Campi A

4

1 reference

17 August 2017

Eoli M

5

1 reference

17 August 2017

Savoiardo M

6

1 reference

17 August 2017

Bianchi G

7

1 reference

17 August 2017

Nespolo A

8

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 July 1990

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

17 August 2017

1 reference

17 August 2017

53

1 reference

17 August 2017

7

1 reference

17 August 2017

554-557

1 reference

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=488128

Studies of Interferon Production and Natural Killing by Lymphocytes from Multiple Sclerosis Patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=488128

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=488128

Diagnosis and classification of multiple sclerosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=488128

Systemic alpha-interferon therapy of multiple sclerosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=488128

Preferential effect of gamma interferon on the synthesis of HLA antigens and their mRNAs in human cells.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=488128

Multicentre double-blind study of effect of intrathecally administered natural human fibroblast interferon on exacerbations of multiple sclerosis

4 September 2018

1 reference

12 December 2020

CSF T-cell subsets in multiple sclerosis: relationship to cerebrospinal fluid myelin basic protein and clinical activity

1 reference

12 December 2020

Mechanisms in multiple sclerosis

1 reference

12 December 2020

Intravenous natural beta interferon treatment of chronic exacerbating-remitting multiple sclerosis: clinical response and MRI/CSF findings

1 reference

12 December 2020

Systemic recombinant alpha-2 interferon therapy in relapsing multiple sclerosis

1 reference

12 December 2020

Lymphocytes from multiple sclerosis patients produce elevated levels of gamma interferon in vitro

1 reference

12 December 2020

Antagonistic effect of interferon-beta on the interferon-gamma-induced expression of Ia antigen in murine macrophages

1 reference

12 December 2020

Interferon production and natural killer (NK) activity in leukocyte cultures from multiple sclerosis patients

1 reference

12 December 2020

Interferon responses of leukocytes in multiple sclerosis

1 reference

12 December 2020

Regulation of natural killer cell cytotoxicity by prostaglandin E in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. Part 1. Association between amount of prostaglandin produced, natu

1 reference

12 December 2020

Modulation of murine natural killer cell activity in vitro and in vivo by recombinant human interferons

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP.53.7.554

1 reference

17 August 2017

1 reference

17 August 2017

1 reference